Gain Therapeutics, Inc. Share Price
NASDAQ: GANX | Micro CapGain Therapeutics, Inc. Stock Performance
Gain Therapeutics, Inc. Share Price Today
As of 30 October 2026, Gain Therapeutics, Inc.'s share price is $1.20. The stock opened at $1.21, compared to its previous close of $1.19. During today's trading session, Gain Therapeutics, Inc.'s share price traded between $1.17 and $1.22, with an average price of $1.19. Over the past 52 weeks, the stock has recorded a high of $4.33 and a low of $1.15. In terms of performance, Gain Therapeutics, Inc.'s share price has declined by 36.51% over the last six months and is down 38.93% on a year-on-year basis.
Gain Therapeutics, Inc. Share Price Chart
Gain Therapeutics, Inc. Quarterly Profit & Loss
All figures in USD
Gain Therapeutics, Inc. Annual Profit & Loss
All figures in USD
About Gain Therapeutics, Inc.
Gain Therapeutics Inc is a clinical-stage biotechnology company developing novel small-molecule therapeutics to treat diseases across several therapeutic areas, including central nervous system (CNS) disorders, lysosomal storage disorders (LSDs), metabolic disorders, and other diseases that can be targeted through protein degradation, such as oncology. The Company's clinical stage product candidate, GT-02287, is being developed for the treatment of Parkinson's disease with and without GBA1 mutations. The Company generated an extensive preclinical data package providing evidence of the mechanism of action.
Gain Therapeutics, Inc. Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Oct 2026 | $1.73 | $1.18 | -32.18% |
Sep 2026 | $1.81 | $1.74 | -6.20% |
Aug 2026 | $1.68 | $1.85 | +10.42% |
Jul 2026 | $2.04 | $1.68 | -17.20% |
Jun 2026 | $1.96 | $2.03 | +2.47% |
May 2026 | $1.83 | $1.98 | +4.76% |
Apr 2026 | $1.95 | $1.89 | -2.07% |
Mar 2026 | $2.54 | $1.93 | -26.05% |
Feb 2026 | $1.85 | $2.61 | +44.20% |
Jan 2026 | $3.20 | $1.81 | -43.88% |
Dec 2025 | $3.40 | $3.23 | -7.73% |
Nov 2025 | $1.99 | $3.50 | +77.86% |